Sedation, Analgesia, and Muscle Relaxation During VV-ECMO Therapy in Patients With Severe Acute Respiratory Syndrome Coronavirus Type 2 (SARS-CoV-2): A Single-Center, Retrospective, Observational Study.

Front Med (Lausanne) · 2021 · PMC8718548 · PMID 34977069

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

From the start of ECMO to the interim stage of ECMO support (INTERIM), the doses of muscle relaxants showed an increasing trend in both the death group and the survival group, except for two patients.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.